JPS6485975A - Novel (1h-imidazole-1-ylmethyl) substituted benzimidazole derivative - Google Patents

Novel (1h-imidazole-1-ylmethyl) substituted benzimidazole derivative

Info

Publication number
JPS6485975A
JPS6485975A JP62228679A JP22867987A JPS6485975A JP S6485975 A JPS6485975 A JP S6485975A JP 62228679 A JP62228679 A JP 62228679A JP 22867987 A JP22867987 A JP 22867987A JP S6485975 A JPS6485975 A JP S6485975A
Authority
JP
Japan
Prior art keywords
ylmethyl
imidazole
novel
benzimidazole derivative
substituted benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62228679A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0587071B2 (enExample
Inventor
Heruman Marugareeta Arufuonsu
Jiyan Etogaruto Furaine Edei
Shiyaruru San Jieraaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JPS6485975A publication Critical patent/JPS6485975A/ja
Publication of JPH0587071B2 publication Critical patent/JPH0587071B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP62228679A 1986-09-15 1987-09-14 Novel (1h-imidazole-1-ylmethyl) substituted benzimidazole derivative Granted JPS6485975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90790386A 1986-09-15 1986-09-15

Publications (2)

Publication Number Publication Date
JPS6485975A true JPS6485975A (en) 1989-03-30
JPH0587071B2 JPH0587071B2 (enExample) 1993-12-15

Family

ID=25424835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62228679A Granted JPS6485975A (en) 1986-09-15 1987-09-14 Novel (1h-imidazole-1-ylmethyl) substituted benzimidazole derivative

Country Status (23)

Country Link
EP (1) EP0260744B1 (enExample)
JP (1) JPS6485975A (enExample)
KR (1) KR960014353B1 (enExample)
CN (1) CN1020903C (enExample)
AU (1) AU595064B2 (enExample)
BG (1) BG61321B2 (enExample)
CA (1) CA1323366C (enExample)
CY (1) CY1803A (enExample)
DE (1) DE3783107T2 (enExample)
DK (1) DK174728B1 (enExample)
ES (1) ES2053524T3 (enExample)
FI (1) FI87781C (enExample)
GR (1) GR3006841T3 (enExample)
HK (1) HK123694A (enExample)
HU (1) HU198039B (enExample)
IE (1) IE60514B1 (enExample)
IL (1) IL83892A (enExample)
NO (1) NO167202C (enExample)
NZ (1) NZ221729A (enExample)
PH (1) PH25022A (enExample)
PT (1) PT85692B (enExample)
SU (1) SU1662350A3 (enExample)
ZA (1) ZA876881B (enExample)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320273A (ja) * 1988-11-29 1991-01-29 Janssen Pharmaceut Nv 皮膚の変調の処置法
WO1995004723A1 (en) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Imidazolylalkylamine derivative and pharmaceutical composition thereof
WO1998037070A1 (en) * 1997-02-21 1998-08-27 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
JP2006513162A (ja) * 2002-11-01 2006-04-20 パラテック ファーマシューティカルズ インコーポレイテッド 転写因子調節化合物およびその使用方法
EP1681290A2 (en) 2000-11-17 2006-07-19 Takeda Pharmaceutical Company Limited Imidazole derivatives, production method thereof and use thereof
JP2007500245A (ja) * 2003-06-10 2007-01-11 スミスクライン ビーチャム コーポレーション 化合物
JP2008514707A (ja) * 2004-09-30 2008-05-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体
JP2008514704A (ja) * 2004-09-30 2008-05-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体
JP2013540145A (ja) * 2010-10-21 2013-10-31 ウニベルシテート デス ザールランデス コルチゾール依存性疾患の治療用の選択的ｃｙｐ１１ｂ１阻害剤
JP2014531459A (ja) * 2011-09-30 2014-11-27 エンドゥ ファーマシューティカルズ，インコーポレイティド 癌処置用ｃｙｐ１７阻害剤としてのイミダゾール誘導体
JP2017014191A (ja) * 2015-07-06 2017-01-19 三星エスディアイ株式会社Samsung SDI Co., Ltd. 化合物、有機膜組成物、有機膜、およびパターン形成方法

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
FR2663028B1 (fr) * 1990-06-08 1994-10-14 Roussel Uclaf Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5216003A (en) * 1992-01-02 1993-06-01 G. D. Searle & Co. Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
PL313769A1 (en) * 1993-09-30 1996-07-22 Yamanouchi Pharma Co Ltd Azole derivative and pharmaceutical composition thereof
MX9603316A (es) * 1994-02-18 1997-02-28 Janssen Pharmaceutica Nv (+)-liarozol enantiomericamente puro.
NZ279228A (en) * 1994-02-18 1997-11-24 Janssen Pharmaceutica Nv Laevorotarory imidazoyl-methyl benzimidazole derivatives (liarozole)
GB9418443D0 (en) * 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
US5696127A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US6696459B1 (en) 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
RU2191774C2 (ru) * 1994-12-22 2002-10-27 Лайджэнд Фармасьютикалз Инкорпорейтед Соединения-модуляторы стероидных рецепторов и способы
TW316902B (enExample) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
WO1996026927A1 (en) * 1995-03-01 1996-09-06 Yamanouchi Pharmaceutical Co., Ltd. Imidazole derivatives and medicinal composition thereof
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
DE19535500A1 (de) * 1995-09-25 1997-03-27 Bayer Ag Verfahren zur Herstellung von 3-Chlor-3'-nitro-4'-methoxybenzophenon
ATE303365T1 (de) * 1995-12-28 2005-09-15 Fujisawa Pharmaceutical Co Benzimidazolderivate
KR100365312B1 (ko) 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
AU730369B2 (en) * 1996-11-25 2001-03-08 Board Of Regents Of The University Of Nebraska, The Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
TW453999B (en) 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
ATE270277T1 (de) 1997-12-11 2004-07-15 Janssen Pharmaceutica Nv Anilide als vitamin-a-säure-mimetika
DE19831985A1 (de) 1998-07-16 2000-01-20 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
CA2375843A1 (en) * 1999-06-04 2000-12-14 Qi Zhao Compositions and methods for inhibiting cell death
HRP20020733A2 (en) 2000-03-16 2005-02-28 F. Hoffmann - La Roche Ag Carboxylic acid derivatives as ip antagonists
DE60144246D1 (de) 2000-11-20 2011-04-28 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US6492517B1 (en) * 2001-07-19 2002-12-10 Air Products And Chemicals, Inc. Method for preparing halomethyl heterocyclic compounds
JP4634037B2 (ja) * 2001-11-16 2011-02-16 日本ケミファ株式会社 キサンチンオキシダーゼ阻害剤
FR2860235A1 (fr) * 2003-09-29 2005-04-01 Yang Ji Chemical Company Ltd Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
CA2562763A1 (en) 2004-04-23 2006-07-20 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
MY149459A (en) * 2006-01-24 2013-08-30 Janssen Pharmaceutica Nv Novel 2-substituted benzimidazoles as selective androgen receptor modulator (sarms)
AU2007215247B2 (en) 2006-02-10 2012-12-13 Transtech Pharma, Llc Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
KR101307497B1 (ko) * 2006-04-19 2013-09-11 주식회사 동진쎄미켐 디이미다졸계 화합물 및 이를 이용한 유기발광소자
CN100496308C (zh) * 2006-06-02 2009-06-10 上海烟草（集团）公司 造纸法再造烟叶半逆流多级萃取工艺
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives
AU2008256926B2 (en) * 2007-05-23 2013-09-19 Allergan, Inc. ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
DE102009038950A1 (de) 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue antiparasitäre Kombination von Wirkstoffen
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
JP2024536342A (ja) * 2021-10-04 2024-10-04 ボルト バイオセラピューティクス、インコーポレーテッド 非対称ビス－ベンゾイミダゾールｓｔｉｎｇアゴニスト免疫複合体及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (enExample) * 1980-10-23 1984-07-13 Pfizer
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320273A (ja) * 1988-11-29 1991-01-29 Janssen Pharmaceut Nv 皮膚の変調の処置法
WO1995004723A1 (en) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Imidazolylalkylamine derivative and pharmaceutical composition thereof
WO1998037070A1 (en) * 1997-02-21 1998-08-27 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
EP1681290A2 (en) 2000-11-17 2006-07-19 Takeda Pharmaceutical Company Limited Imidazole derivatives, production method thereof and use thereof
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
JP2006513162A (ja) * 2002-11-01 2006-04-20 パラテック ファーマシューティカルズ インコーポレイテッド 転写因子調節化合物およびその使用方法
JP2007500245A (ja) * 2003-06-10 2007-01-11 スミスクライン ビーチャム コーポレーション 化合物
JP2008514707A (ja) * 2004-09-30 2008-05-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体
JP2008514704A (ja) * 2004-09-30 2008-05-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体
JP2013540145A (ja) * 2010-10-21 2013-10-31 ウニベルシテート デス ザールランデス コルチゾール依存性疾患の治療用の選択的ｃｙｐ１１ｂ１阻害剤
JP2014531459A (ja) * 2011-09-30 2014-11-27 エンドゥ ファーマシューティカルズ，インコーポレイティド 癌処置用ｃｙｐ１７阻害剤としてのイミダゾール誘導体
JP2017014191A (ja) * 2015-07-06 2017-01-19 三星エスディアイ株式会社Samsung SDI Co., Ltd. 化合物、有機膜組成物、有機膜、およびパターン形成方法

Also Published As

Publication number Publication date
CN1020903C (zh) 1993-05-26
KR880003935A (ko) 1988-06-01
HU198039B (en) 1989-07-28
NO873840L (no) 1988-03-16
GR3006841T3 (enExample) 1993-06-30
PH25022A (en) 1991-01-28
AU595064B2 (en) 1990-03-22
DK479487D0 (da) 1987-09-14
CA1323366C (en) 1993-10-19
CY1803A (en) 1987-09-09
IE60514B1 (en) 1994-07-27
DK174728B1 (da) 2003-10-06
FI87781B (fi) 1992-11-13
SU1662350A3 (ru) 1991-07-07
IE872487L (en) 1988-03-15
DK479487A (da) 1988-03-16
NO873840D0 (no) 1987-09-14
EP0260744A2 (en) 1988-03-23
FI873977A0 (fi) 1987-09-14
AU7838587A (en) 1988-04-14
EP0260744B1 (en) 1992-12-16
ES2053524T3 (es) 1994-08-01
PT85692A (en) 1987-10-01
KR960014353B1 (ko) 1996-10-15
IL83892A (en) 1991-11-21
NZ221729A (en) 1989-07-27
DE3783107D1 (de) 1993-01-28
IL83892A0 (en) 1988-02-29
DE3783107T2 (de) 1993-04-22
ZA876881B (en) 1989-04-26
HK123694A (en) 1994-11-18
FI873977A7 (fi) 1988-03-16
CN87106423A (zh) 1988-04-20
JPH0587071B2 (enExample) 1993-12-15
NO167202C (no) 1991-10-16
BG61321B2 (bg) 1997-05-30
NO167202B (no) 1991-07-08
EP0260744A3 (en) 1989-01-18
FI87781C (fi) 1993-02-25
HUT45051A (en) 1988-05-30
PT85692B (pt) 1990-06-29

Similar Documents

Publication Publication Date Title
JPS6485975A (en) Novel (1h-imidazole-1-ylmethyl) substituted benzimidazole derivative
AU7596587A (en) Benzimidazole derivatives
IL83589A0 (en) Substituted benzoylphenyl-ureas
GB8705852D0 (en) Difluorobromomethoxyphenyl derivative
IL81209A0 (en) Substituted indoloquinoxalines
AU6867487A (en) Benzimidazole derivatives
GR3001005T3 (en) Novel 18-phenyloestrane derivatives
PH22303A (en) Substituted benzimidazole derivatives
ZA876302B (en) Substituted 1-aryl-3-tert.-butyl-pyrazoles
ZA872433B (en) Substituted aminoxy-propanoates
AU7216287A (en) Benzimidazole derivatives
ZA889194B (en) Novel benzimidazole derivatives
JPS6461477A (en) Benzimidazole derivative
GB8723895D0 (en) Preparing-phenyl-propionic acid derivative
PH24626A (en) Heterocyclic substituted benzimidazoles
ZA875299B (en) Imidazole derivative
GB8705190D0 (en) Substituted pyrimidoindoles
ZA879546B (en) Substituted phenoxypyridines
IE860564L (en) Substituted benzimidazoles
GB8614246D0 (en) Substituted pyrimidoindoles
ZA877869B (en) Substituted amino-ketals
SG118994G (en) (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives
ZA877636B (en) 3-propenylcephem derivative
IE863148L (en) (DI) ALKOXYCARBONYLAMINO-s-TRIAZINE DERIVATIVES
GB8629017D0 (en) Heterocyclic derivative

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071215

Year of fee payment: 14